Published in

Springer, PharmacoEconomics - Open, 5(6), p. 647-656, 2022

DOI: 10.1007/s41669-022-00354-2

Links

Tools

Export citation

Search in Google Scholar

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO